Bruker (BRKR) Net Margin (2010 - 2026)
Bruker posted quarterly Net Margin of 0.43% for Q1 2026, down 175.0% year-on-year from 0.57% in Q1 2025, and up 169.61% on a QoQ basis from 0.61% in Q4 2025.
Bruker (BRKR) has 17 years of Net Margin data on file, last reported at 0.43% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin fell 175.0% year-over-year to 0.43%; the trailing twelve-month figure through Mar 2026 stood at 98.06% (down 10037.0% YoY), and the FY2025 full-year result was 117.19%, down 12055.0% from the prior year.
- Net Margin for Q1 2026 stood at 0.43%, up from 0.61% in the prior quarter.
- Across five years, Net Margin topped out at 24.05% in Q4 2023 and bottomed at 7.25% in Q3 2025.
- The 5-year median for Net Margin is 7.05% (2024), against an average of 6.53%.
- The widest annual swing landed in 2023, when Net Margin soared 1030 bps; it then sank 2265 bps in 2024.
- A 5-year view of Net Margin shows it stood at 13.75% in 2022, then surged by 75 bps to 24.05% in 2023, then slumped by 94 bps to 1.4% in 2024, then plunged by 144 bps to 0.61% in 2025, then surged by 170 bps to 0.43% in 2026.
- The last three Net Margin figures came in at 0.43% (Q1 2026), 0.61% (Q4 2025), and 7.25% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 12.75% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 16.74% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.01% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Bruker | 8.89 Bn | 8.77 Bn | 379.80 Mn | 0.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.43% |
| Dec 31, 2025 | -0.61% |
| Sep 30, 2025 | -7.25% |
| Jun 30, 2025 | 0.45% |
| Mar 31, 2025 | 2.17% |
| Dec 31, 2024 | 1.40% |
| Sep 30, 2024 | 4.73% |
| Jun 30, 2024 | 0.95% |
| Mar 31, 2024 | 7.05% |
| Dec 31, 2023 | 24.05% |
| Sep 30, 2023 | 11.86% |
| Jun 30, 2023 | 8.37% |
| Mar 31, 2023 | 11.16% |
| Dec 31, 2022 | 13.75% |
| Sep 30, 2022 | 13.79% |
| Jun 30, 2022 | 8.41% |
| Mar 31, 2022 | 10.35% |
| Dec 31, 2021 | 11.08% |
| Sep 30, 2021 | 14.30% |
| Jun 30, 2021 | 10.09% |
| Mar 31, 2021 | 10.22% |
| Dec 31, 2020 | 10.98% |
| Sep 30, 2020 | 10.62% |
| Jun 30, 2020 | 5.68% |
| Mar 31, 2020 | 2.48% |
| Dec 31, 2019 | 11.44% |
| Sep 30, 2019 | 11.76% |
| Jun 30, 2019 | 7.45% |
| Mar 31, 2019 | 6.68% |
| Dec 31, 2018 | 14.11% |
| Sep 30, 2018 | 9.30% |
| Jun 30, 2018 | 7.03% |
| Mar 31, 2018 | 6.25% |
| Dec 31, 2017 | -0.64% |
| Sep 30, 2017 | 8.49% |
| Jun 30, 2017 | 5.64% |
| Mar 31, 2017 | 5.61% |
| Dec 31, 2016 | 14.67% |
| Sep 30, 2016 | 11.81% |
| Jun 30, 2016 | 3.90% |
| Mar 31, 2016 | 6.29% |
| Dec 31, 2015 | 12.84% |
| Sep 30, 2015 | 2.98% |
| Jun 30, 2015 | 5.53% |
| Mar 31, 2015 | 1.84% |
| Dec 31, 2014 | 5.14% |
| Sep 30, 2014 | 1.31% |
| Jun 30, 2014 | 3.59% |
| Mar 31, 2014 | 2.05% |
| Dec 31, 2013 | 6.38% |
| Sep 30, 2013 | 3.78% |
| Jun 30, 2013 | 5.03% |
| Mar 31, 2013 | 1.37% |
| Dec 31, 2012 | 2.47% |
| Sep 30, 2012 | 8.87% |
| Jun 30, 2012 | 2.35% |
| Mar 31, 2012 | 3.72% |
| Dec 31, 2011 | 8.23% |
| Sep 30, 2011 | 4.73% |
| Jun 30, 2011 | 5.51% |
| Mar 31, 2011 | 3.17% |
| Dec 31, 2010 | 7.04% |
| Sep 30, 2010 | 8.83% |
| Jun 30, 2010 | 7.51% |
| Mar 31, 2010 | 5.80% |